Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 1 - 50 out of 10,070

Document Document Title
WO/2016/063671A1
Provided is an ellagic acid dispersion composition that contains: an aqueous medium; solid particles which contain ellagic acid and have an average particle diameter of 200 nm or less; and at least one type of surfactant selected from am...  
WO/2016/061873A1
Liver-protecting sober-up tea and a preparation method therefor. The tea is prepared from 7-12 g of flowers of kudzuvine, 6-8 g of dendranthemamorifolium, 8-16 g of cassia seeds, 8-10 g of mung beans, 6-12 g of glycyrrhiza uralensis fisc...  
WO/2016/065360A1
The disclosure provides thiol-containing alkyl fatty acid and vitamin D compound formulations for intravenous, parenteral or oral administration. The compositions of the present technology have optimal controlled bioavailability and are ...  
WO/2016/062125A1
Disclosed is an anti-fatigue preparation, health care product or food using a reduced coenzyme II as an active component. The experiments show that it can obviously prolong the weight-bearing swimming time of a mouse, increase the reserv...  
WO/2016/061872A1
Sober-up tea, prepared from the following materials by weight: 6-8 g of chrysanthemum, 8-16 g of mulberry leaves, 6-12 g of glycyrrhiza uralensis fisch, 7-12 g of biota orientalis, 5-8 g of salvia miltiorrhiza, 3-8 g of cortex phellodend...  
WO/2016/058193A1
A traditional Chinese medicine composition for treating suboptimal health, and a preparation method for same, the components and parts by weight of the composition for treating suboptimal health being: 25-35 parts by weight Folium artemi...  
WO/2016/061264A1
The present disclosure relates generally to conjugates and their uses and production. More particularly, it concerns conjugates comprising an A44 or K39 gingipain adhesin peptide, or fragment thereof (e.g., an A44/K39 peptide portion) co...  
WO/2016/056648A1
The present invention addresses the problem of providing a simple and versatile method for stabilizing 2-O-α-D-glucosyl-L-ascorbic acid in an acidic aqueous medium. The problem is solved by providing a method for stabilizing 2-O-α-D-gl...  
WO/2016/052656A1
An autophagy inducing agent that comprises at least one member selected from a compound represented by structural formula (A), a compound represented by structural formula (B), and a compound represented by structural formula (C).  
WO/2016/053953A1
Provided are nutritional supplement preparations and methods for enhancing the outcome of a non-invasive tissue remodeling procedure, for providing the nutritional supplement to a subject, and for preparing such supplements. A synergisti...  
WO/2016/051213A1
The present invention relates to a compound capable of inhibiting PAR by forming a supramolecular structure with PAR, for use in inhibiting PAR or for use in treating or preventing a disease susceptible to PAR inhibition. The present inv...  
WO/2016/035790A1
The purpose of the present invention is to provide an erythrocyte function improving agent that has both high antioxidative effect and excellent migration ability to erythrocytes and is capable of effectively protecting erythrocytes agai...  
WO/2016/031605A1
The present invention solves various problems associated with conventional external preparations used for ameliorating skin diseases which have been issues of concern. The purpose of the present invention is to provide an external prepar...  
WO/2016/031651A1
Provided is a method for producing a solid dispersion whereby the solubility in water of a hardly soluble polyphenol can be improved. A method for producing a solid dispersion containing an amorphous hardly soluble polyphenol, said metho...  
WO/2016/032448A1
The method of treating venomous bites, such as those from snakes and scorpions, involves treatment by the administration of a therapeutically effective amount of an aqueous extract of the fruit of Juniperus phoenicea, or pharmaceutically...  
WO/2016/032924A1
The present disclosure is directed to random, acrylic co-polymers that are useful in transdermal applications. Methods of making and using the described co-polymers are also described.  
WO/2016/031908A1
The purpose of the present invention is to provide an adsorbent for oral administration, said adsorbent being capable of adsorbing a large amount of indole in the presence of bile acid. The problem can be solved by providing the adsorben...  
WO/2016/029158A3
In one embodiment, the present application discloses a method of reducing senescence in a mammal by reducing the concentration of non-ferritin iron within the mammal, comprising the administration of a therapeutically effective amount of...  
WO/2016/024339A1
[Problem] To provide a cell repair agent capable of repairing cells that have been damaged due to the oxidizing power of substances such as acidic electrolyzed water, and a disinfection system capable of safely and efficiently facilitati...  
WO/2016/020288A1
Disclosed are compounds active towards nuclear receptors, pharmaceutical compositions containing the compounds and use of the compounds in therapy.  
WO/2016/011800A1
The present invention provides uses of a recombination ganoderma lucidum immunomodulatory protein (rLZ-8) in senescence delay medicines. According to the measurement of the content of the total protein, the growth hormone, the sex hormon...  
WO/2016/005563A1
The present invention relates to a homeopathic agent allowing smokers to quit smoking, method for its production and its use as a medicament in smoking cessation therapy. The agent allowing smokers to quit smoking is characterized in tha...  
WO/2016/001686A1
The invention relates to a succinate dehydrogenase inhibitor or a prodrug and/or a pharmaceutically acceptable salt thereof for use in the treatment or prevention of reperfusion injury, such as ischemia-reperfusion injury, by inhibiting ...  
WO/2016/004418A1
Disclosed herein are methods of treating a subject having an altered NRF2/KEAP1 pathway, and compounds and compositions useful in such treatment. Also disclosed herein are methods of evaluating whether to administer a compound that inhib...  
WO/2015/193716A1
The present invention relates to a phytochemical(s) rich herbal extract. In particular, the invention provides a flavonoid and phenolics rich extract from plant(s) belonging to family comprising but not limited to Elaeocarpaceae. The inv...  
WO/2015/191827A1
A method for reducing muscle damage and/or oxidative stress in active mammals as disclosed. In one embodiment, the mammals are administered a carnitine supplement. The L-carnitine supplement may be administered without any other pharmace...  
WO/2015/184545A1
The present disclosure provides a process for obtaining protein-enriched preparations from potatoes as well as such preparations comprising patatin and/or proteinase inhibitors. The process broadly comprises enzymatically treated de-star...  
WO/2015/186806A1
Provided is a placenta extract that contains an active ingredient at a high concentration and is scarcely colored and, therefore, suitably usable for cosmetics and foods in which appearance and flavor are highly appreciated. The placenta...  
WO/2015/180485A1
The present invention relates to an amantadine nitrate compound having a neuroprotective effect and a preparation and a medical use thereof. The compound has the structure of the general formula (I). The compound has multiple mechanisms ...  
WO/2015/183963A3
Disclosed herein are methods and compositions for the treatment and/or prevention of diseases or conditions comprising administration of redox-active parabenzoquinones (RPBQs), and/or naturally or artificially occurring derivatives, anal...  
WO/2015/181096A1
The invention provides an oral composition which can improve systemic symptoms such as sensitivity to cold. The oral composition includes, as its effective component, a red vine leaf extract to improve a symptom selected from the group c...  
WO/2015/172400A1
A pharmaceutical composition for treating infertility, comprising the following raw materials: 10-20 parts by weight of radix rehmanniae preparata, 10-20 parts by weight of radix paeoniae alba, 10-20 parts by weight of cornus officinalis...  
WO/2015/174475A1
Provided is a composition for oral intake, having improved oral absorption of curcumin and/or an analog thereof and being capable of being easily and inexpensively produced. A complex of curcumin and/or an analog thereof and a water-solu...  
WO/2015/170605A1
The present invention addresses the problem of providing a food or drink that is capable of lowering the blood alcohol level after drinking an alcoholic beverage(s). To solve this problem, provided is a food or drink that contains water-...  
WO/2015/161766A1
The present invention relates to a choline salt of a selenium-containing compound, and preparation method and use thereof. The structure of the selenium-containing compound choline salt of the present invention is as represented by formu...  
WO/2015/163165A1
[Problem] The present invention addresses the problem of providing a composition useful in the fields of food, cosmetics and pharmaceuticals, said composition being capable of synergistically enhancing antioxidant action. [Solution] The ...  
WO/2015/159272A3
Curcumin compositions herein are described for improving muscle performance, endurance capacity and resistance to fatigue, when administered in effective amounts to a subject in need of such improvement. The compositions are comprised of...  
WO/2015/161200A1
A three component composition for use in the treatment of an autoimmune disease where the first component comprises a bimodal synthetic carbon particle mixture; the second component comprises a bimodal synthetic carbon particle mixture a...  
WO/2015/158031A1
A DNA molecule comprising a sequence represented by SEQ ID NO:1, a pichia pastoris recombinant plasmid into which the DNA molecule is inserted, and a pichia pastoris recombinant bacterium for converting the pichia pastoris recombinant pl...  
WO/2015/154897A1
The present invention provides means and methods for treating disorders of copper metabolism in the brain of a subject comprising administering a therapeutically effective amount of chelators of copper encapsulated into liposomes which a...  
WO/2015/151001A1
The present invention relates to the compound of Formula (I) wherein the substituents are as described herein, and their use in a medicine for the treatment of diseases, disorders associated with the inhibition of Voltage-gated sodium ch...  
WO/2015/150824A1
The invention relates to compounds in the treatment or prevention of disorders associated with Lamin A and/or Lamin C depletion or LMNA mutations, such as laminopathy, premature ageing disorders, normal ageing and cancer(such as a cancer...  
WO/2015/149168A1
A process for producing a distilled ethanol product comprising an antioxidant component and an ethanol component is described. In the process, plant matter containing antioxidants is washed, frozen and exposed to an input volume of ethan...  
WO/2015/148522A1
This invention is about the compositions and methods for assessing and treating vascular endothelial dysfunction. Various aspects provide a method for treatment of vascular endothelial dysfunction, comprising administering a composition ...  
WO/2015/142218A1
The invention relates to medicine, particularly to neurology and cardiology, and also to surgery and traumatology, and specifically relates to medicinal agents exhibiting cytoprotective activity in the presence of ischemia-reperfusion...  
WO/2015/142924A1
Multivalent cation compositions of partially desulfated heparins are presented. Multivalent cation compositions of the disclosure can be formulated at high concentrations. The compositions, processes for making the compositions, unit dos...  
WO/2015/137499A3
 A hydrogen molecule-supplying exterior body (1) for producing a hydrogen-containing biological application solution, said hydrogen molecule-supplying exterior body (1) being provided with a water vapor-permeable container (12) in whic...  
WO/2015/137499A2
 A hydrogen molecule-supplying exterior body (1) for producing a hydrogen-containing biological application solution, said hydrogen molecule-supplying exterior body (1) being provided with a water vapor-permeable container (12) in whic...  
WO/2015/133716A1
The present invention relates to a pharmaceutical composition for the prevention and treatment of cell or tissue damage caused by radiation comprising hesperetin or the pharmaceutically acceptable salts thereof as an active ingredient. P...  
WO/2015/127714A1
Provided is an application of baicalin in preparation of a drug for treating ricin poisoning. A Hela cytoprotection test and a mouse ricin poisoning model have verified the recovery effect of baicalin on ricin poisoning.  

Matches 1 - 50 out of 10,070